학술논문
ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products
Document Type
Article
Author
Talarico, R.R.; Marinello, D.; Tani, C.; Mosca, M.; Ramirez, G.A.; Torre, E.D.; Barreira, S.C.; Fonseca, J.E.; Khmelinskii, N.; Romão, V.C.; Cardamone, C.; Triggianese, P.; Aguilera, S.; Andersen, J.; Avcin, T.; Benistan, K.; Bertsias, G.; Bortoluzzi, A.; Bouillot, C.; Bulina, I.; Burmester, G.R.; Callens, S.; Carreira, P.E.; Cervera, R.; Cutolo, M.; Sulli, A.; Damian, L.; Pamfil, C.; Rednic, S.; Faria, R.; Galetti, I.; Hachulla, E.; Iaccarino, L.; Jacobsen, S.; Limper, M.; Meyer, A.; Moroncini, G.; Nagy, G.; Olesinska, M.; Pileckyte, M.; Pistello, M.; Richez, C.; Schneider, M.; Sciascia, S.; Scirè, C.A.; Simonini, G.; Smith, V.; Tas, S.W.; Tincani, A.; Vonk, M.C.; Tektonidou, M.
Source
In: Clinical and Experimental Rheumatology . (Clinical and Experimental Rheumatology, March 2023, 41(3):543-553)
Subject
Language
English
ISSN
1593098X
0392856X
0392856X